Institutional members access full text with Ovid®

Share this article on:

The Quick Inventory of Depressive Symptomatology, Clinician Rated and Self-report: A Psychometric Assessment in Chinese Americans With Major Depressive Disorder

Yeung, Albert MD, ScD*; Feldman, Gregory PhD*†; Pedrelli, Paola PhD*; Hails, Kate BA*; Fava, Maurizio MD*; Reyes, Tracy BS; Mundt, James C. PhD

The Journal of Nervous and Mental Disease: August 2012 - Volume 200 - Issue 8 - p 712–715
doi: 10.1097/NMD.0b013e318261413d
Original Articles

This study aimed to investigate the psychometric properties of the Chinese translations of the Quick Inventory of Depressive Symptomatology (QIDS16), including the Clinician-Rated (QIDS-C16), Self-report (QIDS-SR16), and Interactive Voice Response (QIDS-SR-IVR16) formats. Thirty depressed Chinese Americans were assessed with Chinese translations of the QIDS-SR16, QIDS-SR-IVR16, and QIDS-C16. Cronbach alpha estimates of internal scale consistency on the QIDS-SR16, QIDS-SR-IVR16, and QIDS-C16 were 0.70, 0.74, and 0.79, respectively. Intercorrelations among the measures were QIDS-SR16 and QIDS-SR-IVR16, r = 0.79; QIDS-SR16 and QIDS-C16, r = 0.61; and QIDS-SR-IVR16 and QIDS-C16, r = 0.69 (all p values < 0.01). The areas under the curve for the receiver operating characteristics of the QIDS-SR16 and QIDS-SR-IVR16 were 0.78 (95% confidence interval, 0.61–0.95) and 0.81 (95% confidence interval, 0.65–0.96), respectively. The respective screening sensitivities/specificities were 0.73/0.74 and 0.86/0.58. The Chinese translations of the QIDS16 have adequate psychometric properties and may be useful tools for depression screening.

*Depression Clinical and Research Program, Massachusetts General Hospital, Boston, MA; †Simmons College, Boston, MA; and ‡Center for Psychological Consulting, Madison, WI.

Send reprint requests to Albert Yeung, MD, ScD, Depression Clinical and Research Program, Massachusetts General Hospital, One Bowdoin Square, 6/F, Boston, MA 02114. E-mail:

© 2012 Lippincott Williams & Wilkins, Inc.